Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Impact of Crohn’s Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis

Cui, De-Jun MD, PhD1; Zhao, Xun MM1; Hu, Mei MM1

American Journal of Gastroenterology: January 2017 - Volume 112 - Issue 1 - p 185
doi: 10.1038/ajg.2016.339
LETTERS TO THE EDITOR
Buy

1Department of Gastroenterology, National Institution of Drug Clinical Trial, The Affiliated People’s Hospital of Guizhou Medical University, Guiyang, China

Correspondence: De-Jun Cui, MD, PhD, Department of Gastroenterology, The Affiliated People’s Hospital of Guizhou Medical University, National Institution of Drug Clinical Trial, No. 83, East Zhongshan Road, Nanming District, Guiyang 550002, China. E-mail: hxcuidj@163.com

Guarantor of the article: De-Jun Cui, MD, PhD.

Specific author contributions: De-Jun Cui and Mei Hu wrote the paper. De-Jun Cui and Xun Zhao had the original idea for the paper. All authors reviewed and approved the final draft of the paper.

Financial support: None.

Potential competing interests: None.

© The American College of Gastroenterology 2017. All Rights Reserved.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website